Drug-induced autophagic myopathies: Exploring pathophysiology with immunolabelling and proteomics
Journal of Neuropathology & Experimental Neurology · 08.08.2026
DOI: 10.1093/jnen/nlag074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, online erschienen am 08.08.2026. Verfasst von Beatrice Labella und 17 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular Functional Unit, Department of Neuropathology, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DREAMS, Deutsche Gesellschaft für Muskelkranke e.V., the European Regional Development Fund.
Abstract (Originalsprache)
Hydroxychloroquine (HCQ), chloroquine (CQ), and colchicine are widely used to treat autoimmune and inflammatory diseases but can cause toxic autophagic vacuolar myopathies. This study investigates the pathological mechanisms of HCQ/CQ- and colchicine-induced myopathies through integrated clinical, histopathological, ultrastructural, and proteomic analyses. Nine patients with clinicopathologically defined toxic myopathy (HCQ/CQ, n = 4; colchicine, n = 5) were included. Muscle biopsies were analyzed using histoenzymology, immunohistochemistry for autophagic and immune markers, electron microscopy, and proteomic profiling in selected cases. Clinically, both groups presented with proximal muscle weakness and myalgia after variable drug exposure. Histology revealed rimmed and non-rimmed vacuoles, especially in HCQ/CQ cases, and myofibrillar disorganization; the latter predominated in colchicine-treated patients. Electron microscopy confirmed myofibrillar disruption in colchicine-treated patients and autophagosomes with curvilinear bodies in HCQ/CQ cases. Immunohistochemistry showed MHC-I upregulation, heterogeneous C5b-9 deposition, and accumulation of LC3 and p62, with evidence of endoplasmic reticulum stress and transcriptional dysregulation by GRP170 overexpression and cytoplasmic MeCP2 redistribution. Proteomic analysis revealed a shared molecular signature involving immune activation, extracellular matrix remodeling, cytoskeletal stress, mitochondrial dysfunction, and dysregulation of the autophagy-lysosome pathway. Overall, HCQ/CQ- and colchicine-induced myopathies converge on common mechanisms of autophagic impairment, immune activation, and disrupted muscle homeostasis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuromuscular Functional Unit, Department of Neuropathology, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France.
- Neuromuscular Morphology Unit, Myology Institute, Groupe Hospitalier Universitaire Pitié-Salpêtrière, Paris, France.
- Sorbonne Université, AP-HP, Myology Research Center UMR974, Pitié-Salpêtrière Hospital, Paris, France.
- Department of Neurology, Nord/Est/Île-de-France Neuromuscular Reference Center, FHU PHENIX, AP-HP, Raymond-Poincaré Hospital, Garches, France.
- Myology Unit, Department of Clinical Physiology and Exercise, University Hospital of Saint-Etienne, Saint-Priest-en-Jarez, France.
- Interuniversity Laboratory of Human Movement Biology, Jean-Monnet University, Saint-Etienne, France.
ORCID-Profile: Beatrice Labella, Teresinha Evangelista
Förderung
- DREAMS
- Deutsche Gesellschaft für Muskelkranke e.V.
- the European Regional Development Fund
- the "Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen"
- "Der Regierende Bürgermeister von Berlin, Senatskanzlei Wissenschaft und Forschung"
- the "Bundesministerium für Forschung, Technologie und Raumfahrt" (BMFTR)
- the “Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen”
- “Der Regierende Bürgermeister von Berlin, Senatskanzlei Wissenschaft und Forschung”
Zitieren
APA
Labella, B., Leonard-Louis, S., Lacene, E., Beuvin, M., Chanut, A., Madelaine, A., Brochier, G., Labasse, C., Maisonobe, T., Benveniste, O., Lefeuvre, C., Guémy, C., Laforêt, P., Merlet, A. N., Féasson, L., Hentschel, A., Roos, A., & Evangelista, T. (2026). Drug-induced autophagic myopathies: Exploring pathophysiology with immunolabelling and proteomics. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlag074
Vancouver
Labella B, Leonard-Louis S, Lacene E, Beuvin M, Chanut A, Madelaine A, et al. Drug-induced autophagic myopathies: Exploring pathophysiology with immunolabelling and proteomics. Journal of Neuropathology & Experimental Neurology. 2026. doi:10.1093/jnen/nlag074
BibTeX
@article{Labella2026,
author = {Labella, Beatrice and Leonard-Louis, Sarah and Lacene, Emmanuelle and Beuvin, Maud and Chanut, Anaïs and Madelaine, Angeline and Brochier, Guy and Labasse, Clémence and Maisonobe, Thierry and Benveniste, Olivier and Lefeuvre, Claire and Guémy, Clément and Laforêt, Pascal and Merlet, Angèle N and Féasson, Léonard and Hentschel, Andreas and Roos, Andreas and Evangelista, Teresinha},
title = {Drug-induced autophagic myopathies: Exploring pathophysiology with immunolabelling and proteomics},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2026},
doi = {10.1093/jnen/nlag074}
}
EUVIMED